| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/21/2011 | CN101773506B Composition of cefpiramide and sodium glycinate or special solvent composition containing sodium glycinate |
| 09/21/2011 | CN101724085B Method for purifying capsular polysaccharide |
| 09/21/2011 | CN101721366B Components and preparation method of beta-lactam injection |
| 09/21/2011 | CN101717425B 11,23,24-Tris-oxygen-butyryl alisol A ,as well as medicine composite and application thereof |
| 09/21/2011 | CN101708223B Preparation method, quality control method and application for Chinese medicinal compound indigowoad leaf preparation |
| 09/21/2011 | CN101708215B Method for extracting triterpenes from schisandra chinansis |
| 09/21/2011 | CN101705233B Recombinant human herpes simplex virus I protein HSV I gG and application thereof |
| 09/21/2011 | CN101700376B Traditional Chinese medicine for treating virus B hepatitis |
| 09/21/2011 | CN101693747B Specific polysaccharide preparation process |
| 09/21/2011 | CN101658469B Cleaning-free hand sanitizer and preparation thereof |
| 09/21/2011 | CN101647788B Florfenicol microcapsule and preparation method thereof |
| 09/21/2011 | CN101637447B Sitafloxacin hydrate injection and preparation method thereof |
| 09/21/2011 | CN101623329B Method for extracting paper mulberry alkaloid and application of paper mulberry alkaloid |
| 09/21/2011 | CN101590034B Application of compound catechin in resisting drug-resistant strains |
| 09/21/2011 | CN101491680B Infectious bursal disease live-vaccine heat-proof freeze-dry protectant and preparation method thereof |
| 09/21/2011 | CN101475639B Mixed yolk antibody for preventing and treating duck infectious serositis and preparation thereof |
| 09/21/2011 | CN101461913B Chinese medicinal composition for treating tuberculosis |
| 09/21/2011 | CN101454295B Anti-foot-and-mouth disease virus agent for animal belonging to family suidae or sheep |
| 09/21/2011 | CN101450173B Traditional Chinese medicine composition and preparation method and use thereof |
| 09/21/2011 | CN101445532B Preparation method of azithromycin monohydrate crystal |
| 09/21/2011 | CN101411790B Oral Chinese medicine for treating pneumonia type influenza |
| 09/21/2011 | CN101376675B Antimicrobial peptide |
| 09/21/2011 | CN101306186B Traditional Chinese medicine taken orally for treating Qi stagnation and blood stasis type zoster |
| 09/21/2011 | CN101306080B Elsholtzia spray |
| 09/21/2011 | CN101306079B Decoction for treating poliomyelitis |
| 09/21/2011 | CN101270134B Method for preparing pericarpium lagenariae theine |
| 09/21/2011 | CN101254171B Spray containing small molecule disturbance ribonucleic acid |
| 09/21/2011 | CN101224217B Skeleton type roxithromycin sustained release pellet capsule |
| 09/21/2011 | CN101222913B Pharmaceutical composition comprising 2 , 3-dihydro-6-nitroimidazo [2 , 1-B] oxazole derivatives |
| 09/21/2011 | CN101204452B Tincture medicine for verruca plana |
| 09/21/2011 | CN101199685B Smoked washing medicament for treating chronicity conjunctivitis |
| 09/21/2011 | CN101199649B Chinese medicine agent for treating ribbon herpes |
| 09/21/2011 | CN101194989B Exterior applied medicament for treating zoster |
| 09/21/2011 | CN101132795B Compounds useful in the treatment of HIV |
| 09/21/2011 | CN101085785B Purine compounds for curing hepatitis B, preparation method and use thereof, and composition containing the compounds |
| 09/20/2011 | US8022176 FAS peptide mimetics and uses thereof |
| 09/20/2011 | US8022077 Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof |
| 09/20/2011 | US8022041 Prodrug of an ICE inhibitor |
| 09/20/2011 | US8022033 Echinocandin/carbohydrate complexes |
| 09/20/2011 | US8021879 Adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof |
| 09/20/2011 | US8021861 Pathogenic Escherichia coli associated protein |
| 09/20/2011 | US8021832 Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
| 09/20/2011 | US8021671 Pro-apoptotic bacterial vaccines to enhance cellular immune responses |
| 09/20/2011 | US8021656 Probiotics for gut neuromuscular functions |
| 09/20/2011 | CA2573346C Hepatitis c inhibitor peptide analogs |
| 09/20/2011 | CA2548668C Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 09/20/2011 | CA2506532C Anhydrous crystalline azido cytosine hemisulfate derivative |
| 09/20/2011 | CA2492874C Taste masked oral composition of telithromycin |
| 09/20/2011 | CA2482512C Improved viral purification methods |
| 09/20/2011 | CA2474156C Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of ns3 (hepatitis c) |
| 09/20/2011 | CA2474035C Macrocyclic peptides active against the hepatitis c virus |
| 09/20/2011 | CA2473686C Novel cytokine zcytor17 ligand |
| 09/20/2011 | CA2467774C Solubilized topoisomerase poisons |
| 09/20/2011 | CA2462903C Beta-lactamyl vasopressin v1a antagonists |
| 09/20/2011 | CA2455966C Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 09/20/2011 | CA2453817C Organophosphorus compounds for the activation of gamma/delta t-cells |
| 09/20/2011 | CA2440067C Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same |
| 09/20/2011 | CA2426348C Retrovirus isolated from humans |
| 09/20/2011 | CA2411726C Use of ingenanes in treating a pkc-related condition or disorder |
| 09/20/2011 | CA2377977C Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 09/20/2011 | CA2367373C Medicinal compositions |
| 09/20/2011 | CA2367149C Combination of antibiotic and nucleic acid binding compound for bacterial antibiotic resistance |
| 09/20/2011 | CA2337100C Polypeptides of lymphodendritic cell adhesion molecules (ldcams) and polynucleotides encoding the same |
| 09/20/2011 | CA2217522C Isolated frpb nucleic acid molecule and vaccine |
| 09/15/2011 | WO2011113065A2 Pegylated polyplexes for polynucleotide delivery |
| 09/15/2011 | WO2011113060A2 Antiviral compounds and methods of use thereof |
| 09/15/2011 | WO2011113013A2 Methods and compositions for treating viral or virally-induced conditions |
| 09/15/2011 | WO2011112983A2 Psrp is a protective antigen against pneumococcal infection |
| 09/15/2011 | WO2011112850A2 Humanized and chimeric anti-properdin antibodies |
| 09/15/2011 | WO2011112769A1 Compounds for the treatment of hepatitis c |
| 09/15/2011 | WO2011112761A1 Crystalline salts of a potent hcv inhibitor |
| 09/15/2011 | WO2011112516A1 Treating and preventing hepatitis c virus infection using c-raf kinase antisense oligonucleotides |
| 09/15/2011 | WO2011112429A1 Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases |
| 09/15/2011 | WO2011112191A1 Compounds for the treatment of hepatitis c |
| 09/15/2011 | WO2011111971A2 Method for preparing (r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl)-5-(substituted methyl)oxazolidin-2-one derivatives |
| 09/15/2011 | WO2011111738A1 Novel fki-4429 substance and method for producing same |
| 09/15/2011 | WO2011111077A1 1, 2, 4-triazole derivatives and their anti mycobacterial activity |
| 09/15/2011 | WO2011110613A1 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| 09/15/2011 | WO2011110570A1 Treatment of streptococcal infections |
| 09/15/2011 | WO2011110546A2 Pharmaceutical composition comprising an inhibitor of shp-2 and screening method |
| 09/15/2011 | WO2011110225A1 Adhesive patch for therapeutic agent delivery |
| 09/15/2011 | WO2011110084A1 Method for preparing isovalerylspiramycin i, ii or iii and pharmaceutical composition containing compound thereof |
| 09/15/2011 | WO2011110049A1 Anti-hiv fusion polypeptide and use thereof |
| 09/15/2011 | WO2011080765A3 Recombinant human bivalent diabody against rabies virus and uses thereof |
| 09/15/2011 | WO2011057169A3 Improved silver oxide formulations |
| 09/15/2011 | WO2011053789A3 Pharmaceutical composition and methods to enhance cytotoxic t-cell recognition and maintain t-cell memory against a pathogenic disease |
| 09/15/2011 | WO2011034582A3 Hiv-1 antibodies |
| 09/15/2011 | WO2010147836A9 Combination therapies using antibacterial aminoglycoside compounds |
| 09/15/2011 | WO2010137032A3 Novel polymorphic forms of elvitegravir and its pharmaceutically acceptable salts |
| 09/15/2011 | WO2010132839A9 Aminoglycoside dosing regimens |
| 09/15/2011 | WO2010132768A9 Antibacterial derivatives of sisomicin |
| 09/15/2011 | US20110224723 Cyanoacrylate tissue adhesives |
| 09/15/2011 | US20110224675 Minimally invasive treatment of vertebra (mitv) using a calcium phosphate combination bone cement |
| 09/15/2011 | US20110224302 Difluorophenyldiacylhydrazide derivatives |
| 09/15/2011 | US20110224301 Hmgb1 expression and protective role of semapimod in nec |
| 09/15/2011 | US20110224297 Methods of administering prostratin and structural analogs thereof |
| 09/15/2011 | US20110224289 Compounds of the pterocarpanquinone family, method for preparing the same, pharmaceutical composition containing the new compounds of the pterocarpanquinone family, uses and therapeutic method |
| 09/15/2011 | US20110224285 Oligomeric compounds for the modulation of hif-1a expression |
| 09/15/2011 | US20110224249 Novel Hydrate Form |
| 09/15/2011 | US20110224242 Styrlyquinolines, their process of preparation and their therapeutic uses |